American Journal of Neuroradiology 26:1551-1562, June-July 2005
© 2005 American Society of Neuroradiology
BRAIN
Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt-Jakob Disease: High Sensitivity and Specificity for Diagnosis
a Department of Radiology, University of California, San Francisco
b Department of Neurology, University of California, San Francisco
Address reprint requests to William P. Dillon, MD, P.O. Box 0628, University of California, San Francisco, San Francisco, CA 74143-0628
BACKGROUND AND PURPOSE: Abnormalities on diffusion-weighted images (DWIs) and fluid-attenuated inversion recovery (FLAIR) images are reported in Creutzfeldt-Jakob disease (CJD). To our knowledge, no large study has been conducted to determine the sensitivity and specificity of DWI and FLAIR imaging for diagnosing CJD.
METHODS: Two neuroradiologists, blinded to diagnosis, retrospectively evaluated DWI and FLAIR images from 40 patients with probable or definite CJD and 53 control subjects with other forms of dementia and rated the likelihood of CJD on the basis of the imaging findings.
RESULTS: DWI and FLAIR imaging was 91% sensitive, 95% specific, and 94% accurate for CJD. Interrater reliability was high (
= 0.93). Sensitivity was higher for DWI than FLAIR imaging. Abnormalities involved cortex and deep gray matter (striatum and/or thalamus) in 68% of patients with CJD, cortex alone in 24%, and deep gray matter alone in 5%. The most typical and specific patterns were corresponding hyperintensity on both FLAIR images and DWIs confined to the gray matter in the cortex, striatum, medial and/or posterior thalamus, or a combination of these areas. Narrow-window soft-copy review of artifact-free DWIs and FLAIR images and recognition of the normal variation in cortical signal intensity proved critical for successful differentiation of CJD from other dementias.
CONCLUSION: Because specific patterns of abnormality on DWI and FLAIR images are highly sensitive and specific for CJD, these sequences should be performed whenever CJD is suspected.
This article has been cited by other articles:
 |
|
 |
|
  S. Haik, D. Galanaud, M. G. Linguraru, K. Peoc'h, N. Privat, B. A. Faucheux, N. Ayache, J.-J. Hauw, D. Dormont, and J.-P. Brandel In Vivo Detection of Thalamic Gliosis: A Pathoradiologic Demonstration in Familial Fatal Insomnia Arch Neurol, April 1, 2008; 65(4): 545 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Brown Transmissible spongiform encephalopathy in the 21st century: Neuroscience for the clinical neurologist Neurology, February 26, 2008; 70(9): 713 - 722. [Full Text] [PDF]
|
|
|
|
 |
|
 A Machado, H Soares, H Antunes, Z Magalhaes, C Ferreira, I Baldeiras, M H Ribeiro, I Santana, J Ramalheira, L Castro, et al. Variant Creutzfeldt Jacob disease: the second case in Portugal and in the same geographical region J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 180 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Geschwind, K. A. Josephs, J. E. Parisi, and B. M. Keegan A 54-year-old man with slowness of movement and confusion Neurology, November 6, 2007; 69(19): 1881 - 1887. [Full Text] [PDF]
|
|
|
|
|
|
R G Macfarlane, S J Wroe, J Collinge, T A Yousry, and H R Jager Neuroimaging findings in human prion disease J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 664 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.J. Tschampa, K. Kallenberg, H.A. Kretzschmar, B. Meissner, M. Knauth, H. Urbach, and I. Zerr Pattern of Cortical Changes in Sporadic Creutzfeldt-Jakob Disease AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1114 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ukisu, T. Kushihashi, E. Tanaka, M. Baba, N. Usui, H. Fujisawa, and H. Takenaka Diffusion-weighted MR Imaging of Early-Stage Creutzfeldt-Jakob Disease: Typical and Atypical Manifestations RadioGraphics, October 1, 2006; 26(suppl_1): S191 - S204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-R. Lin, G.S. Young, N.-K. Chen, W.P. Dillon, and S. Wong Creutzfeldt-Jakob Disease Involvement of Rolandic Cortex: A Quantitative Apparent Diffusion Coefficient Evaluation AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1755 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Krasnianski, W. J. Schulz-Schaeffer, K. Kallenberg, B. Meissner, D. A. Collie, S. Roeber, M. Bartl, U. Heinemann, D. Varges, H. A. Kretzschmar, et al. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD Brain, September 1, 2006; 129(9): 2288 - 2296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Lewis, M. Yu, S. J. DeArmond, W. P. Dillon, B. L. Miller, and M. D. Geschwind Human Growth Hormone-Related Iatrogenic Creutzfeldt-Jakob Disease With Abnormal Imaging Arch Neurol, February 1, 2006; 63(2): 288 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Rabinovici, P. N. Wang, J. Levin, L. Cook, M. Pravdin, J. Davis, S. J. DeArmond, N. M. Barbaro, J. Martindale, B. L. Miller, et al. First symptom in sporadic Creutzfeldt-Jakob disease Neurology, January 24, 2006; 66(2): 286 - 287. [Full Text] [PDF]
|
|